Intriguingly, genetic ablation of Nedd4-2 in this diabetic model did not exacerbate kidney disease severity beyond Nedd4-2 loss alone, but corrected metabolic parameters via a reduction of aldosterone levels, restoration of insulin signaling and reduced blood glucose levels. This evidence concerns the gene NEDD4L and kidney disorder.